United States · FDA National Drug Code directory

Diltiazem Hydrochloride

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference
33342-521_850566b1-0c8e-42bc-85fa-c8ee710f34ba
Product NDC
33342-521
Form
CAPSULE, EXTENDED RELEASE
Composition / generic term
Diltiazem Hydrochloride
Labeler
Macleods Pharmaceuticals Limited
Marketing category
ANDA
Marketing start / end (source format)
20230623
Source listing expiry
20271231

Source-listed ingredients

  • DILTIAZEM HYDROCHLORIDE — 120 mg/1

These values do not establish equivalence or a dose recommendation.

Packages

  • 6 CAPSULE, EXTENDED RELEASE in 1 BLISTER PACK (33342-521-02) · 33342-521-02
  • 30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (33342-521-07) · 33342-521-07
  • 90 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (33342-521-10) · 33342-521-10

Source and coverage

Open FDA National Drug Code directory

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →